Delivery Order SPE2DB22D1200-SPE2DB24FN0LU
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,960,168 units of Naloxone HCl 4 mg nasal spray. The firm-fixed-price contract, valued at $3,088.40, has a completion date of June 21, 2024. AmerisourceBergen, a major pharmaceutical distribution company, has extensive experience fulfilling government contracts for a wide range of medical products, including prescription medications,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,671,806 units of 4 mg naloxone HCl nasal spray. The $1,958.16 contract has a completion date of February 16, 2024 and was awarded on February 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract with DLA valued up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4 mg Naloxone Hydrochloride nasal spray. The order has a completion date of January 26, 2024 and a potential value of $5,117.74. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense....
- The Defense Logistics Agency (DLA) awarded a $13,138.72 firm-fixed-price delivery order (SPE2DB22D3016|SPE2DB24FAZJ5) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg naloxone hydrochloride nasal spray. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $41,796.44 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of 4,563,589,049 units of Naloxone HCl 4 mg Nasal Spray. The Delivery Order has a period of performance through February 8, 2024 and uses a Firm Fixed Price pricing type. The contract was awarded on February 7, 2024 with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,315.00, is for the delivery of Naloxone HCl 4 mg nasal spray. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The contract is not set aside and is open to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,199,657 units of Naloxone HCl 4 mg Nasal Spray 2S. The $1,693.44 award has a completion date of January 2, 2024 and was issued on December 29, 2023. Amerisourcebergen Drug Corp, which operates out of its corporate office in Conshohocken, Pennsylvania, has previously received numerous federal contracts from DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,781.16 to AmerisourceBergen Drug Corp for the delivery of Naloxone HCL 4 mg Nasal Spray. This order is part of a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen Drug Corp, valued at $999,999,999.00, that provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government agencies. The contract does not have a set-aside...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NARCAN 4 MG NASAL SPRAY 2S. The contract has a potential value of $1,193.76 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order. The company also holds an indefinite delivery contract (IDC) with DLA, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $10,222.79. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 30, 2025, supporting federal medical procurement needs. The contract is classified as a child order under a larger indefinite delivery contract vehicle and carries no set-aside designation, indicating open...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB24FN0LUDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4 mg Naloxone HCl nasal spray. The contract has a potential value of $1,693.44 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which is not designated as a set-aside. The company also holds an indefinite delivery contract with DLA, valued up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide.
Generated 4/29/24, 9:37 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/29/24 |